Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study
Clinical trial NCT06914908 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06914908
- Sponsor
- Sanofi
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-12
- Primary completion
- 2031-01-29
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.